NNMT, Cancer Risk & 5-Amino-1MQ – Where Science Ends and Assumptions Begin

Alright… this one is interesting.

Because I talk a lot about 5-Amino-1MQ— mainly in the context of fat loss, metabolic health, and keeping weight off long term.

But recently, I was in a conversation with a doctor… and he told me he personally takes it because his mother died from a glioblastoma.

And his reasoning?

👉 It inhibits NNMT 👉 NNMT is involved in certain cancers 👉 So… maybe there’s something there

Now before we go any further—

I am NOT saying 5-Amino prevents or treats cancer. And neither was he.

What he was doing… was taking a known biological pathway and making an informed assumption.

And honestly?

It’s a fascinating one.

NNMT (Nicotinamide N-Methyltransferase) is an enzyme involved in how your body manages:

• Energy production
• NAD+ levels
• Metabolic function
• Aging processes

When NNMT is elevated, it’s associated with:

• Fat storage
• Insulin resistance
• Slower metabolic function
• Lower NAD+ availability

👉 This is why it shows up so strongly in midlife weight gain

And it’s also why I talk so much about 5-Amino-1MQ— because it inhibits NNMT, which can shift the body away from storing fat and toward using energy.

NNMT doesn’t just show up in metabolism.

It’s also upregulated in certain cancers, including:

• Glioblastoma
• Pancreatic cancer
• Bladder cancer
• Ovarian cancer

In these environments, NNMT appears to support:

• Tumor growth
• Cell survival
• Metabolic adaptation

👉 In simple terms: cancer cells may use NNMT to survive.

So researchers have asked:

What happens if we inhibit NNMT?

In early-stage research (cells + animal models), 👉 inhibiting NNMT has shown reductions in tumor growth.

That’s real.

But here’s the key…

We have:

• NNMT is involved in metabolic disease
• NNMT is involved in some cancers
• 5-Amino inhibits NNMT

So the leap becomes:

👉 “Does taking 5-Amino reduce cancer risk?”

And the honest answer is:

We don’t have evidence to say that.

No human trials. No prevention studies.

What we have is a mechanistic connection— and a very interesting one.

Here’s where it gets even more compelling…

NNMT increases with:

• Age
• Obesity
• Insulin resistance

And those same conditions are associated with:

• Higher cancer rates
• More chronic disease
• More metabolic dysfunction

So now we’re looking at a broader picture:

👉 A metabolic environment that becomes more vulnerable over time

And NNMT may be one of the players in that shift.

Not the cause. Not the cure. But part of the story.

This is not a recommendation.

This is not a protocol.

This is simply a lens.

• One enzyme
• One molecule that inhibits it
• Two very different areas of research that overlap

👉 That intersection is worth understanding.

Just remember:

Interesting ≠ proven Mechanism ≠ outcome

If you’ve been following my work, you already know I use and talk about:

• 5-Amino-1MQ
• SLU-PP-332

You can learn more or get them here:

👉 www.joanneleestore.com

Use code:

👉 DAISY for 20% off

⏳ Expires April 1